Description

Tirzepatide (Mounjaro) — 10mg

Tirzepatide is the active compound in Mounjaro — a dual agonist peptide that targets two key metabolic receptors at once: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-receptor activity makes it one of the most studied and talked-about compounds in metabolic research today, offering researchers the ability to investigate two incretin pathways simultaneously with a single compound.

About Tirzepatide
Most GLP-1 compounds only target one receptor. Tirzepatide hits two — and the combined effect on metabolic signalling has made it a major focus of research into glucose regulation, fat metabolism, and appetite control. The GLP-1 pathway helps regulate insulin release and slows gastric emptying; the GIP pathway enhances insulin sensitivity and plays a role in fat storage and energy balance. Together they produce a more comprehensive metabolic signal than either pathway alone.

Key Benefits:
• Dual receptor action — targets both GLP-1 and GIP receptors simultaneously for broader metabolic research coverage
• Glucose regulation — studied for its effects on insulin secretion and blood sugar control models
• Fat metabolism — GIP receptor activity adds a unique dimension to lipid and adipose tissue research
• Appetite and satiety — studied for its effect on hunger signalling pathways in the brain
• Insulin sensitivity — researched for improving how cells respond to insulin across metabolic models
• Cardiovascular markers — emerging research into its effects on heart health and inflammatory biomarkers
• Powerful comparator compound — ideal for studies comparing dual vs. triple receptor agonism alongside Retatrutide

Research Focus Areas
• Dual GLP-1 / GIP receptor agonism and incretin pathway research
• Glucose homeostasis and insulin secretion models
• Adipose tissue metabolism and lipid regulation
• Appetite and satiety neurological signalling
• Insulin sensitivity and metabolic syndrome models
• Cardiovascular and inflammatory biomarker research
• Comparative incretin agonist studies

Specifications
• Total content: 10mg
• Active compound: Tirzepatide
• Form: Lyophilised powder
• Purity: ≥99% — HPLC verified
• Storage: 2–8°C, away from light and moisture

———

Important Notice

This product is supplied strictly for laboratory research use only. It is not intended for human or veterinary use.

By purchasing, the buyer confirms they are a qualified professional or acting on behalf of a licensed research facility and accept full responsibility for safe handling, storage, and use in accordance with all applicable guidelines. No claims are made regarding the safety or effectiveness of this compound outside of a controlled research environment.